Home » Blog » Cancer Moonshot, Drug Pricing, ACA Repeal, and Pharmaceutical Company Acquisitions

Cancer Moonshot, Drug Pricing, ACA Repeal, and Pharmaceutical Company Acquisitions


IP Blog | Dave Melin | January 15, 2017

BioBlog Weekly oncologyThis week’s BioBlog focuses on VP Biden’s plans after he leaves office, pharmaceutical company acquisitions, the drive to repeal and replace the ACA, and the continued battle over drug costs.

At San Francisco Event, Biden Vows to Make Fighting Cancer His Cause

At an event in San Francisco, VP Biden reiterated his intentions to continue his efforts to further cancer research once he leaves office.

Japan’s Takeda Ready for Fresh Acquisitions After $5.2 Billion Ariad Deal

Reuters reports that Takeda Pharmaceutical has acquired the drug company Ariad Pharmaceutical in a deal this week.

Donald Trump Wants Speedy ACA Repeal, Replacement

Trump is calling for a quick repeal and replacement of the Affordable Care Act.

Trump Says Drugmakers ‘Getting Away With Murder’, Cites F-35, Foird, Fiat

This week Trump called for new bidding procedures for drug prices to help curb high drug costs.

AbbVie Vows to Keep Drug Price Increases Below 10 Percent

Drug maker AbbVie has vowed to keep any drug price increases in 2017 under 10 percent.


Topics in this Post:



Leave a Comment

Your email address will not be published. Required fields are marked *